An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice
Qi Yin, Xuelei Pi, Yuanyuan Jiang, Guiping Ren, Zhihang Liu, Han Liu, Mengxia Wang, Wenying Sun, Siyu Li, Zhenqiu Gao, Deshan Li, Jiechao Yin
Topics & Concepts
Ulcerative colitisEtanerceptMedicineInflammatory bowel diseaseColitisTumor necrosis factor alphaPharmacologySuperoxide dismutaseImmunologyInternal medicineGastroenterologyOxidative stressDiseaseInflammatory Bowel DiseasePsoriasis: Treatment and PathogenesisIL-33, ST2, and ILC Pathways